Overview

Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
A Multi-Center, Unblinded, Single-Arm Study to Evaluate Sex Differences in the Acute Effects of PL-3994 on Myocardial cGMP Enhancement and Hemodynamics in Heart Failure with Preserved Ejection Fraction
Phase:
Phase 2
Details
Lead Sponsor:
Palatin Technologies
Treatments:
Pharmaceutical Solutions